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bstract
A powder vaccine intended for aerosol vaccination of poultry was formulated by spray drying a live attenuated Newcastle disease virus with
otential stabilizers (mannitol, trehalose, polyvinylpyrrollidone (PVP), bovine serum albumin (BSA)). Thermodynamic properties, water
orption, particle size distribution, nebulization properties, density and morphology of the powders were evaluated and the virus survival
uring spray drying and storage was determined by incubation in embryonated eggs and subsequent haemagglutination assay. All powders
ad a narrow size distribution with a median volume diameter of ±30m (suitable for primary respiratory vaccination of chickens) and
ood aerosolization characteristics. Four amorphous, hygroscopic formulations were produced (trehalose, trehalose-PVP, trehalose-BSA,
rehalose-PVP-BSA), where addition of BSA was beneficial for virus survival during production and storage at 6 and 25 ◦C. A crystalline,
on-hygroscopic powder (mannitol) had a lower stabilizing capacity during production but maintained the remaining virus titre during storage.
n conclusion, the study demonstrates that it is possible to produce a dry powder formulation of an attenuated live vaccine for mass vaccination
f poultry in a one-step spray drying process.
2007 Elsevier Ltd. All rights reserved.
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. Introduction
The upscaling of the poultry industry can facilitate the
apid spread of infectious diseases over large geographical
reas [1], increasing the significance of disease outbreaks.
he use of efficient and economical vaccinations against
mportant poultry and zoonotic pathogens are of great sig-
ificance in limiting the number and extension of disease
utbreaks [2]. For respiratory infections such as Newcas-
le disease (ND), mass spray and aerosol vaccination with
reconstituted freeze-dried live attenuated vaccine are often
pplied.
∗ Corresponding author. Tel.: +32 92648069; fax: +32 92228236.
E-mail address: Chris.Vervaet@UGent.be (C. Vervaet).
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oi:10.1016/j.vaccine.2007.09.049However, the efficiency of these vaccinations could be
mproved. A first problem is the broad droplet size distri-
ution generated by the nebulizers currently used for liquid
pray and aerosol vaccination: the presence of small, inhal-
ble droplets in a coarse spray for primary vaccination often
esults in post-vaccination reactions [3–5] and a large fraction
f non-inhalable droplets generated by fine aerosol nebulizers
e.g., 10–1000m [6]) reduces the efficiency of secondary
accinations. Furthermore, the efficiency of vaccines admin-
stered by spray or aerosol might be jeopardized due to the
se of tap water for reconstitution (often containing viru-
idal agents, such as chlorines) [7], by large shear forces
hich are applied to the liquid in order to transform it into
roplets [8] and most importantly, due to inactivation of
he vaccine virus by evaporation of droplets after generation
3,5,9].
accine
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These harmful effects could be overcome by formulat-
ng the vaccine in dry powder form with defined particle
ize. Dry powder vaccines have been produced successfully
y mechanical milling of a freeze-dried pellet of a live ND
accine [10,11] and a live measles vaccine [12,13]. The for-
er research never found large-scale application in poultry
ndustry, probably related to difficulties in obtaining defined
arrow particle size spectra. However, spray drying, where a
iquid is transformed in dry powder particles by nebulization
f droplets in hot drying air, has been recommended as an
lternative to freeze drying for the preparation of inhalation
roducts, as it allows to produce individual particles with a
ontrolled size and shape in a one-step process [14–17]. As
t is important in veterinary vaccinology to have inexpensive
accines [18], especially in low-profit sectors such as poultry
ndustry [19], spray drying has the additional advantage of
eing a faster and more cost-effective dehydration process
han freeze drying [20].
The spray drying process can be divided in three major
teps: nebulization of the liquid by means of a nozzle that pro-
ides the energy for droplet formation, drying of the droplets
n the warm air of the drying chamber, and separation of
he resulting powder particles from the drying air. Despite
he application of higher than ambient temperatures during
spray drying process, co-current (i.e., where air and liquid
ow through the drying chamber in the same direction) spray
rying can be used to dry heat-sensitive materials as the mate-
ials are hardly exposed to the higher temperatures. During
vaporation, the temperature of a droplet does not rise above
he wet-bulb temperature (i.e., temperature of the saturated
urface): heat is used for evaporation of liquid and not for
eating of the droplet. As evaporation continues, the original
emperature of the drying air (inlet temperature) decreases
o lower values (outlet temperature). Only when all liquid
as evaporated, the remaining dry particle becomes sensitive
o heating. However, dried particles are immediately trans-
orted to a collection vessel where the temperature of the air
urther decreases [14–16].
Spray drying of heat-sensitive materials for inhalation
uch as proteins has been performed previously. In general,
tabilizing excipients are added to the proteins before spray
rying to prevent degradation during processing and storage,
here immobilization of the labile materials in an amorphous
lass is believed to be advantageous for maintaining the activ-
ty of the incorporated molecules [21–24]. Disaccharides are
mongst the most used excipients, with trehalose being par-
icularly successful [25,26]. However, polyvinylpyrrolidone
PVP) is sometimes added when formulating proteins as a dry
owder to prevent re-crystallization of stabilizing sugars and
he thereby induced inactivation of incorporated labile mate-
ials during storage [27–29]. Also proteins such as albumins
ave been shown to prevent crystallization of spray-dried
nd freeze-dried excipients [21,30]. The resistance to crys-
allization can be evaluated by measuring the glass transition
emperature, which is the temperature at which the transition
rom the glassy to the rubbery state or from a low molec-
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lar mobility to a high molecular mobility (and therefore,
igher risk of crystallization) occurs. PVP and albumins are
nown to increase the glass transition temperature, which
eans that the formulations can be exposed to higher ambi-
nt temperatures before the glass transition occurs. Equally
mportant is a low hygroscopicity of the formulations as water
olecules are known to increase the molecular mobility,
hereby decreasing the glass transition temperature [31–34].
his low hygroscopicity is additionally important when for-
ulating inhalation products as the absorption of moisture
n a powder might induce agglomeration of aerosol particles
17,35].
In this study, the usefulness of spray drying to formulate
n attenuated live ND dry powder vaccine was investigated.
irstly, placebo formulations were characterized for their
rotein stabilizing potential and for their particle size dis-
ribution. The assessment of the protein stabilizing potential
as based on glass transition temperature, residual moisture
ontent, water uptake and crystallization rate [36]. The parti-
le size was compared with the optimal particle size required
or respiratory vaccination of differently aged chickens, being
20 and >5m for primary vaccination of 1-day-old and
-week-old chickens, respectively, and <5 and <10m for
econdary vaccination of 2- and 4-week-old chickens, respec-
ively [37]. Subsequently, an attenuated ND vaccine virus
as spray-dried with the different formulations and the loss
f titre upon drying and storage was evaluated.
. Materials and methods
.1. Spray drying
An experimental spray dryer with a 30m piezo-actuated
ozzle, kindly provided by Niro A/S (Soeborg, Denmark),
as used to produce particles with an extremely narrow size
istribution. The feed solutions were prepared in distilled
ater, with a total concentration of solids of 5% (w/w).
ive different feed solutions were prepared: 5% mannitol
C*Mannidex 16700; Cerestar, Mechelen, Belgium), 5%
rehalose dihydrate (C*Ascend 16400; kindly provided by
erestar), 4% trehalose dihydrate with 1% polyvinylpyrroli-
one (PVP) (Kollidon®30; BASF, Ludwigshaven, Germany),
% trehalose dihydrate with 1% bovine serum albumin (BSA)
Sigma–Aldrich, Steinheim, Germany), and 3% trehalose
ihydrate with 1% PVP and 1% BSA. The feed solutions
ere filtered (paper filter 595, Schleicher & Schuell, Dassel,
ermany) to remove remaining particulates in order to avoid
logging of the nozzle. Then, a feed solution was pumped
o the nozzle (feed rate: 30 ml/h) where a droplet generation
requency of 50 kHz was applied on the feed solution by the
iezo-actuator. The inlet temperature was set at 90 ◦C and the
rying gas flow rate at 25 kg/h, resulting in an outlet temper-
ture of 70 ◦C. The powder was separated from the drying air
sing a cyclone. After production, the powders were stored
t 25 ◦C in glass vials closed with silica-containing stoppers.
8 accine
m
t
d
l
e
5
A
m
d
p
s
t
6
2
2
w
A
s
e
h
c
i
m
b
r
c
t
e
R
t
s
c
l
r
2
w
m
h
B
w
n
t
m
t
(
w
r
s
p
c
H
t
2
e
o
(
l
w
T
p
m
t
p
c
a
l
b
o
6
t
b
M
t
b
a
e
2
2
a
J
e
c
p
2
t
U
p
i
T
m
u
b
t308 E.A. Corbanie et al. / V
After drying and evaluating the placebo powders, the for-
ulations were used to produce the powder vaccines. For
his purpose, the attenuated Clone 30 strain of the ND virus,
eveloped by Intervet International (Boxmeer, the Nether-
ands), was harvested from the allantoic fluid of embryonated
ggs and added to the feed solution in a concentration of 107
0% egg infectious doses (EID50) per ml of feed solution.
s 100 ml of a feed solution with 5% solids was dried, a
aximum titre of 109 EID50 was incorporated in 5 g pow-
er. The collection vessel was regularly exchanged during
roduction to prevent heating of the vaccine particles. The
ame drying conditions as described before were used and
he powder vaccines were stored in sealed aluminium bags at
and 25 ◦C.
.2. Solid state characterization
.2.1. Dynamic vapour sorption (DVS)
Water sorption isotherms of the powder formulations
ere determined gravimetrically at 25 ± 0.1 ◦C using a DVS
dvantage 1 with a Cahn D200 microbalance (Surface Mea-
urement Systems, London, Great Britain). During a DVS
xperiment, materials are exposed to a changing relative
umidity (RH), which is regulated by electronic mass flow
ontrollers that mix saturated and dry carrier gas streams. The
ncrease or decrease of RH induces a change of mass of the
aterial due to moisture uptake or release, which is measured
y comparing the mass of the sample cup with the mass of a
eference cup, both attached to the microbalance [34].
Between 10 and 20 mg powder was weighed in the sample
up of the DVS instrument, subjected to a drying step in order
o bring the sample to a constant weight and subsequently
xposed to increasing RH (using 10% increments up to 90%
H). Following the sorption phase, the samples were exposed
o a decreasing RH (in steps of 10% until 0% RH). Each
tep continued until equilibrium was reached (i.e., when the
hange of mass was smaller than 0.002% min−1 during at
east 10 min) or until 6 h had passed. The mass change was
ecorded every minute with a resolution of ±0.1g.
.2.2. Karl Fischer titration
The residual moisture content after spray drying and the
ater content after 1 year storage were evaluated by an auto-
ated Karl Fischer titration. The samples (±50 mg) were
eated in a Mettler DO337 oven (Mettler-Toledo, Beersel,
elgium) at 130 ◦C during 10 min. During this period the
ater vapour from the samples was transferred by a dry
itrogen flow to the titration vessel of the Karl Fischer titra-
or (Mettler DL35; Mettler-Toledo), containing absolute, dry
ethanol (Biosolve, Valkenswaard, the Netherlands). After
hese 10 min, the titration with Hydranal® Composite 2
Sigma–Aldrich) started automatically. During this titration,
ater molecules react stoichiometrically with the Hydranal®
eagent (one-component reagent for Karl Fischer titration);
ubsequently, the volume of Hydranal® used to reach the end-
oint of titration (potentiometrically determined) is used to
p
e
(
t25 (2007) 8306–8317
alculate the percentage of water present in the sample (1 ml
ydranal® = ±2 mg water). All titrations were performed in
riplicate.
.2.3. Differential scanning calorimetry (DSC)
The thermodynamic behavior (i.e., exothermic or heat lib-
rating and endothermic or heat consuming energy changes)
f the powders was determined on a DSC 2920 calorimeter
TA Instruments, Ghent, Belgium), operated in the modu-
ated mode. This means that the powders are linearly heated
ith an overlaying sinusoidal modulation of the temperature.
he energy difference of processes occurring in a sample
an and an empty reference pan placed in the calorimeter are
easured during a DSC experiment as function of time and
emperature [38]. The DSC was calibrated with indium (tem-
erature calibration) and with sapphire (heat capacity and
ell constant calibration). The sample cell was purged with
nitrogen flow of 25 ml/min. The samples (5–10 mg) were
oaded in sealed aluminium pans (TA Instruments), equili-
rated at −20 ◦C and heated to 200 ◦C with a scanning rate
f 2 ◦C/min and modulation amplitude of ±0.318 ◦C every
0 s. The glass transition temperature (Tg) was recognized on
he reversing heat flow curve as an endothermic shift of the
aseline and determined as the midpoint of this transition.
elting was seen as endothermic peaks, where the melting
emperature Tm was determined after extrapolation on the
aseline (onset melting temperature). Crystallization temper-
tures (Tc) were determined as the peak temperatures of the
xothermic crystallization peaks.
.3. Particle characterization
.3.1. Scanning electron microscopy (SEM)
A thin layer of powder was dispersed on a sample holder
nd coated with platinum in an Auto Fine Coater (JFC-1300;
eol, Zaventem, Belgium). A Jeol JSM 5600 LV scanning
lectron microscope (Jeol) was used to evaluate the parti-
le morphology. Powders were evaluated immediately after
roduction and after 1 year storage.
.3.2. Particle size distribution
Particle size distributions were measured by laser diffrac-
ion (Mastersizer-S long bed; Malvern Instruments, Malvern,
K). Laser diffractometry is based on the fact that particles,
assing through a laser beam, scatter light at an angle that
ncreases logarithmically when the particle size decreases.
he instrument consists of a laser source that generates
onochromatic light of high intensity, a sample presentation
nit that ensures that the material is passed through the laser
eam, and a diode array detector that detects the intensity of
he diffracted light beams.
To obtain the size distribution of individual particles, the
owders were suspended in Miglyol 812N (capric triglyc-
ride; Sasol, Witten, Germany) with 0.2% TweenTM 80
Federa, Brussels, Belgium) and subsequently circulated
hrough the wet sample presentation cell of the laser diffrac-
accine
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or. Additionally, the particle size distribution of dispersed
owders was determined to verify if the powders could be
e-agglomerated into individual particles during air-assisted
ispersion. The experimental powder dispersion device was
onstructed from a vacuum flask, in which air (10 l/min;
.5 bar) was blown with an Omron CX3 compressor (Omron,
oofddorp, the Netherlands). The air flow suspended the
articles in air and carried them through the outlet of the
ask into the dry powder sample presentation unit of the
article sizing equipment. The environmental conditions
uring powder dispersion were 21 ◦C and 35% RH. An
dditional experiment was performed for the trehalose-PVP-
SA formulation using dry air (dried using silica gel) to
isperse the powder. All measurements were performed in
riplicate.
The results obtained from laser scattering experiments
re volume-based and the obtained diameters are calculated
s the diameters of spheres that have the same volume as
he measured (non-spherical) particles. The volume-based
ize distribution is particularly useful when characterizing
erosols in human and veterinary medicine as it is more
aluable to know the deposited mass than the deposited num-
er of aerosol particles. For example, 100 particles of 1m
representing a total volume of 52.3m3) will have a lower
herapeutic effect than 1 particle of 10m (representing a vol-
me of 523m3), despite that the 1m particles are present
n a higher number. The volume particle size distributions
s measured, are characterized by the diameters D[v, 0.1],
[v, 0.5] and D[v, 0.9]. This means that 10, 50, and 90%
f the total measured volume of particles, respectively, is
epresented by particles that have a volume that is smaller
han the volume of a sphere with the corresponding diam-
ter. D[v, 0.5] is also known as the mass median diameter
r MMD. The span or width of the distribution is defined
s (D[v, 0.9] − D[v, 0.1])/D[v, 0.5], and is zero when the
istribution is perfectly monodisperse.
.3.3. Particle density
A helium pycnometer (AccuPyc 1330; Micromeritics,
russels, Belgium) was used to evaluate the true density of
he spray-dried powders. The pycnometer determines the vol-
me of a sample from the change of pressure of helium gas
n a calibrated cell when the sample is introduced in the cell.
he mass of the sample is accurately determined before start-
ng the experiment and allows to calculate the density of the
owder particles (density = mass/volume).
.4. Evaluation of vaccine virus stability
ND virus titres in the original feed solutions and in
he corresponding powders were determined by titration in
0–11-day-old embryonated chicken eggs. Ten-fold dilution
eries were prepared in phosphate buffered saline (PBS) with
% penicillin-streptomycin. Subsequently, 100l of each
ilution was inoculated in the allantoic cavity of five eggs.
fter 72 h incubation at 37 ◦C, allantoic fluids were collected
3
s
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nd tested for haemagglutinating activity with chicken red
lood cells (RBCs). Fifty microliters of the allantoic fluid
f each egg was pipetted in a U-bottomed microtitre plate
containing 50l PBS per well) and two-fold dilutions were
ade across the plate. Afterwards, 50l of a 0.5% chicken
BC suspension was added to each well, the fluids in the well
late were gently mixed and RBCs were allowed to settle dur-
ng 1 h at room temperature. In case ND virus was present,
aemagglutination was detected. Virus titres were calculated
sing the method of Reed and Muench [39] and expressed as
og10 EID50 per gram powder. The detection limit was 102.7
ID50 per gram of powder. Comparison of the titre in the feed
olution with the titre in the corresponding powder formula-
ion allowed to evaluate the stability of the virus during the
rying process. Virus titrations were also performed on pow-
ers stored for 1, 5 and 10 months at 6 and 25 ◦C in order to
valuate the ability of the different formulations to stabilize
he vaccine during storage.
.5. Statistical analysis
Water content, as determined by Karl Fischer titration, was
valuated by two-way ANOVA testing (SPSS version 12.0;
PSS, Chicago, IL, USA) for the influence of storage time
nd formulation. The particle size data were also analyzed
sing two-way ANOVA tests: a first analysis evaluated the
nfluence of dispersion method and formulation, while in a
econd analysis the influence of storage time and formulation
as assessed. Four particle size parameters were included in
ach analysis, namely D[v, 0.1], D[v, 0.5], D[v, 0.9], and
pan. True densities were compared statistically for the influ-
nce of formulation type by a one-way ANOVA. Differences
ere considered significant at P < 0.05.
In all analyses, the normality of the data was evaluated
ith the Kolmogorov–Smirnov test. The homogeneity of
ariances was checked and the data were transformed where
ecessary. For the evaluation of water content, the main effect
f the formulation ignoring the effect of storage time or the
ain effect of the storage time ignoring the formulation effect
as investigated when no significant interaction was present.
hen the interaction between both factors was significant,
he simple effects of the formulation within each storage time
r the simple effects of the storage time within each formu-
ation were investigated with a Bonferroni post hoc test. The
ame procedure was followed when analyzing the particle
ize data.
. Results
.1. Solid state characterization.1.1. Dynamic vapour sorption (DVS)
The water sorption and desorption profiles at 25 ◦C are
hown in Fig. 1. Mannitol was the least hygroscopic pow-
er, absorbing only 1% of water when exposed to 90% RH.
8310 E.A. Corbanie et al. / Vaccine 25 (2007) 8306–8317
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tig. 1. Water sorption (black) and desorption curves (grey) obtained from dyn
D) trehalose-BSA and (E) trehalose-PVP-BSA.
he other formulations had a similar water sorption up to
0% RH and absorbed about 5 and 11% water at 30 and
0% RH, respectively. Below 30% RH the water sorption
ate was lower in comparison to the sorption rate above 30%
H, resulting in an inflection point in the absorption curve.
bove 50% RH, the influence of the composition of the
ormulation was evident. Pure trehalose did not sorb addi-
ional water when exposed to higher RH and did not release
ater during the desorption phase. When PVP and/or BSA
ere added to trehalose, no plateau in water sorption was
bserved and the water content increased up to maximum
alues of 23, 17 and 27% for trehalose-PVP, trehalose-BSA
nd trehalose-PVP-BSA, respectively. At a specific RH (cor-
elated with a specific water content), the raw DVS data
not shown) of these combined powders showed a decrease
n mass during the sorption phase: for trehalose-PVP this
ccurred at 70% RH (18% water content decreased to 15%),
M
t
N
Papour sorption experiments. (A) Mannitol; (B) trehalose; (C) trehalose-PVP;
or trehalose-BSA at 60% RH (15% water content decreased
o 11%), and for trehalose-PVP-BSA at 80% RH (22% water
ontent decreased to 19%). The desorption phase of these
owders was similar when water evaporated from the sam-
les. However, hysteresis occurred and 3–5% water was still
resent in the samples at the end of the sorption/desorption
ycle.
.1.2. Residual moisture content and moisture uptake
uring storage
Table 1 shows the residual moisture content (Karl Fis-
her titration) after spray drying and after 1 year storage of
he powders in glass vials with silica-containing stoppers.annitol retained significantly less water during produc-
ion (<1.0%) compared to the other formulations (3.0–3.5%).
o significant differences were detected between trehalose-
VP, trehalose-BSA and trehalose-PVP-BSA. Storage during
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Table 1
Average moisture content (±S.D.) (n = 3) and glass transition temperature (n = 1) immediately after production and after 1 year storage at 25 ◦C in glass vials
closed with silica-containing stoppers
Immediately after production 1 Year after production
Formulation Moisture content (%) Glass transition temperature (◦C) Moisture content (%) Glass transition temperature (◦C)
Mannitol 0.7 ± 0.1 – 1.4 ± 0.1a –
Trehalose 3.1 ± 0.1 71.6 7.9 ± 0.0a 38.3
Trehalose-PVP 3.4 ± 0.1b 75.8 8.9 ± 0.1a,c 41.1
Trehalose-BSA 3.4 ± 0.1b 76.8 7.2 ± 0.1a 48.0
Trehalose-PVP-BSA 3.3 ± 0.1b 82.1 8.8 ± 0.1a,c 47.4
T oisture
W a’) afte
F r conten
1
m
c
s
t
3
F
ahe moisture content immediately after production represents the residual m
ater content of all formulations increased significantly (superscript letter ‘
ormulations with the same superscript letters ‘b’ and ‘c’ have similar wate
year significantly increased the moisture content of the
annitol formulation to 1.4%, while the other formulations
ontained 7–9% water. The PVP-containing formulations
howed similar (±9%), but significantly higher results than
hose of the other formulations.
d
y
t
ig. 2. Surface morphology of the different formulations immediately after produ
nd (E) trehalose-PVP-BSA.content after spray drying.
r 1 year storage in glass vials.
ts (no significant difference).
.1.3. Thermodynamic properties
Glass transition temperatures (Tg) of the amorphous pow-
ers, determined immediately after production and after 1
ear storage, are shown in Table 1. The Tg of pure spray-dried
rehalose (72 ◦C) increased to values between 76 and 82 ◦C
ction. (A) Mannitol; (B) trehalose; (C) trehalose-PVP; (D) trehalose-BSA
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Table 2
Average particle size distribution parameters (±S.D.) (n = 3) of powders measured after suspension in Miglyol + 0.2% TweenTM 80, compared to the particle
size distribution after air-assisted dispersion with the experimental powder dispersion device
Formulation Dispersion methoda D[v, 0.1] (m) D[v, 0.5] (m) D[v, 0.9] (m) Span
Mannitol Susp. 19.5 ± 0.8 28.2 ± 0.2 37.8 ± 0.4 0.7 ± 0.0
Aer. 22.8 ± 0.3b 29.3 ± 1.0b 43.2 ± 3.7b 0.7 ± 0.1
Trehalose Susp. 4.1 ± 0.7 24.8 ± 0.6 37.0 ± 1.0 1.3 ± 0.4
Aer. 20.4 ± 0.2b 24.1 ± 0.4 29.4 ± 1.3b 0.4 ± 0.0b
Trehalose-PVP Susp. 3.2 ± 0.1 25.8 ± 0.1 30.3 ± 0.0 1.1 ± 0.0
Aer. 21.8 ± 0.5b 26.5 ± 1.1 32.6 ± 1.6b 0.4 ± 0.0b
Trehalose-BSA Susp. 16.1 ± 0.3 28.2 ± 0.0 36.2 ± 0.2 0.7 ± 0.0
Aer. 20.6 ± 0.6b 27.9 ± 0.1 38.3 ± 0.7 0.6 ± 0.0
Trehalose-PVP-BSA Susp. 19.5 ± 0.9 29.0 ± 0.0 36.1 ± 0.5 0.6 ± 0.0
Aer. 25.3 ± 0.2b 34.1 ± 1.3b 305.3 ± 258.5b 8.1 ± 7.5b
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Ta Dispersion method: Susp. = suspended in wet dispersion cell of Masters
ental powder dispersion device into dry powder cell of Mastersizer.
b Significant difference (P < 0.05) between the primary and aerosolized pa
ith the addition of other excipients. After 1 year storage
t 25 ◦C, Tg values decreased, the PVP-containing powders
aving the largest reduction (35 ◦C). At both time points,
he BSA-containing powders had the highest Tg values. The
pray-dried mannitol powder was crystalline with a melting
emperature of 163 ◦C.
Upon heating of pure trehalose, a crystallization peak was
bserved at 55 ◦C above Tg. This crystallization peak was
elayed to 70 and 90 ◦C above Tg for trehalose-PVP and
rehalose-BSA, respectively. The trehalose-PVP-BSA pow-
er did not show non-isothermal crystallization within the
canned temperature range.
.2. Particle characterization
.2.1. Scanning electron microscopy (SEM)
The different powder particles are visualized in Fig. 2.
ost of the mannitol particles were regular shaped, but some
f the particles seemed to be fragmented. In contrast, tre-
alose particles were nearly perfect spheres. The addition
f PVP to trehalose induced the formation of raisin-like,
rinkled spherical particles, with the indentations becom-
ng more pronounced when additionally BSA was included
n the formulation. Combining trehalose with BSA (but
ithout PVP) resulted in completely collapsed particles.
i
t
v
able 3
verage particle size distribution parameters (±S.D.) (n = 3) of powders measured af
nd after 1 year storage at 25 ◦C in glass vials with silica-containing stoppers
ormulation Storage time D[v, 0.1] (m)
annitol – 19.5 ± 0.8
1 year 19.9 ± 1.4
rehalose – 4.1 ± 0.7
1 year 14.9 ± 0.4a
rehalose-PVP – 3.2 ± 0.1
1 year 4.1 ± 0.0a
rehalose-BSA – 16.1 ± 0.3
1 year 12.9 ± 5.5
rehalose-PVP-BSA – 19.5 ± 0.9
1 year 6.1 ± 2.1a
a Significant differences (P < 0.05) between the particle size immediately after prh Miglyol + 0.2% TweenTM 80 as medium; Aer. = aerosolized with experi-
ize.
n general, all powders showed a very homogeneous size
istribution.
.2.2. Dispersability of spray-dried powders
Table 2 compares the particle size distribution after sus-
ending the powders in Miglyol (primary particle size) and
fter air-assisted dispersion with the experimental powder
ispersion device. Most parameters were similar after air-
ssisted dispersion (although the small differences were in
ome cases statistically different related to the good repro-
ucibility of the measurements). Only for mannitol and
rehalose-PVP-BSA, all three size parameters increased sig-
ificantly. These differences were small, except for D[v, 0.9]
f trehalose-PVP-BSA which increased from 36 to 305m
pon dispersion, thereby increasing the span value signifi-
antly. However, when the powder was dispersed with a dry
ir stream, D[v, 0.1], D[v, 0.5] and D[v, 0.9] were 21, 29
nd 37m, respectively.
.2.3. Inﬂuence of storage time on particle size
istributionThe particle size distribution (determined in Miglyol)
mmediately after production is compared in Table 3 with
he distribution after storing the powders for 1 year in glass
ials with silica-containing stoppers. Similar to the evalua-
ter suspension in Miglyol + 0.2% TweenTM 80 immediately after production
D[v, 0.5] (m) D[v, 0.9] (m) Span
28.2 ± 0.2 37.8 ± 0.4 0.7 ± 0.0
28.7 ± 0.3 39.9 ± 0.5a 0.7 ± 0.0
24.8 ± 0.6 37.0 ± 1.0 1.3 ± 0.4
38.1 ± 2.6a 97.4 ± 3.4a 2.2 ± 0.1a
25.8 ± 0.1 30.3 ± 0.0 1.1 ± 0.0
26.9 ± 0.2a 37.4 ± 1.7a 1.2 ± 0.0a
28.2 ± 0.0 36.2 ± 0.2 0.7 ± 0.0
29.7 ± 0.0a 40.9 ± 0.3a 0.9 ± 0.2a
29.0 ± 0.0 36.1 ± 0.5 0.6 ± 0.0
29.3 ± 0.0 37.9 ± 0.0a 1.1 ± 0.0a
oduction and after 1 year storage at 25 ◦C.
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Table 4
Inactivation of Clone 30 live attenuated ND vaccine virus during the spray drying process
Formulation EID50 in total amount of feed EID50 in total amount of powder EID50 per gram powder
Mannitol 109.0 104.9 104.3
Trehalose 108.5 108.3 107.6
Trehalose-PVP 108.0 107.2 106.5
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ion of the dispersability, most differences were small and not
elevant from a practical point-of-view (even if statistically
ifferent). Only pure trehalose showed a clear shift towards
arger particle sizes after 1 year storage. This was confirmed
y SEM pictures as the trehalose particles agglomerated due
o the formation of solid bridges between the primary par-
icles (Fig. 3). No particle agglomeration was observed on
EM pictures of the other powders.
.2.4. Particle density
The true density of the formulations, with significant dif-
erences between all formulations, was influenced by the
ncorporated excipients. The pure components mannitol and
rehalose had a density of 1.42 and 1.52 g/cm3, respectively.
he addition of PVP or BSA to trehalose lowered the den-
ity to 1.45 and 1.47 g/cm3, respectively, and the additive
ffect of PVP and BSA resulted in the lowest density for the
rehalose-PVP-BSA formulation (1.40 g/cm3).
.3. Evaluation of vaccine virus stability
The effect of spray drying on the infectivity of the Clone
0 ND vaccine virus can be derived from Table 4, where
he titre before drying (i.e., in the total volume of feed solu-
ion) is compared with the titre after drying (i.e., in the total
mount of spray-dried solids). Additionally, the latter titre
as expressed per gram powder. Three formulations retained
he vaccine activity completely: trehalose, trehalose-BSA
nd trehalose-PVP-BSA. The addition of PVP to trehalose
ig. 3. Agglomerate of trehalose particles, formed after 1 year storage at
5 ◦C in glass vials with silica-containing stoppers.
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ecreased the vaccine titre with 0.8 log10 EID50, but the
argest loss of activity was seen in the mannitol formulation,
s the titre was reduced with 4.1 log10 EID50.
Fig. 4 shows the loss of titre (calculated per gram of pow-
er) in function of storage time, taking the titre immediately
fter production as a reference. In general, the vaccine titre
ecreased at higher storage temperature and longer storage
ime. However, the degree of inactivation depended on the
xcipients of the formulation. Although mannitol was not
ble to stabilize the vaccine during the drying process, the
eduction of titre was only 0.3 log10 EID50 when stored at
◦C for 10 months. In contrast, the reduction of titre in the
ther formulations ranged between 1.2 (trehalose-BSA) and
.1 (trehalose-PVP) log10 EID50 under the same storage con-
itions. The titre of trehalose-BSA and trehalose-PVP-BSA
accines stabilized during the last 5 months of storage at
◦C. Storage at 25 ◦C resulted in a considerable decrease
f titre in the trehalose and trehalose-PVP formulations,
hile the loss of titre in trehalose-BSA and trehalose-PVP-
SA formulations was lower. Additionally, the resulting titres
fter 10 months storage at 25 ◦C of the trehalose-BSA and
rehalose-PVP-BSA formulation were only approximately 2
nd 1 log10 EID50 lower in comparison to storage at 6 ◦C.
he incorporation of the Clone 30 vaccine in trehalose-BSA
nd trehalose-PVP-BSA thus resulted in the highest retention
f viral activity, with residual virus titres of 106.5 and 106.0
ID50, respectively, when stored for 10 months at 6 ◦C and
04.3 and 104.7 EID50, respectively, after 10 months storage
t 25 ◦C.
. Discussion
When developing an inhalable dry powder vaccine,
he interaction between powder properties such as water
ptake, glass transition temperature and particle charac-
eristics largely influences the potential application of a
ormulation. The water sorption profiles obtained from
he DVS experiments (Fig. 1) indicated clear differences
etween the formulations, which are mainly related to differ-
nt thermodynamic properties. The mannitol powder, which
as crystalline after spray drying, hardly absorbed water,
hile the amorphous trehalose-containing formulations were
ygroscopic even at low RH. The larger water uptake of amor-
hous formulations is due to bulk absorption of water, while
rystalline material only adsorbs water on readily accessi-
le water binding sites at the surface [40]. This also explains
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Fig. 4. Loss of infectivity titre of Clone 30 live attenuated ND vaccine virus incorporated in powder formulations in function of storage temperature and time
i are exp
r t 25 ◦C.
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wn comparison to the titres obtained immediately after production. Results
esults for storage at 6 ◦C, and the lighter bars showing results for storage a
i.e., 102.7 EID50 per gram of powder) and the loss of titre should then be co
hy mannitol had a much lower residual moisture content
fter spray drying compared to the other formulations. The
mount of water absorbed by amorphous materials depended
n the excipients used: the addition of the hydrophilic high
olecular weight PVP increased the amount of water incor-
orated in the trehalose matrix after exposure to 90% RH
DVS experiments) and after 1 year storage (Karl Fischer
itration).
The non-isothermal Tg (Table 1), as determined from the
SC thermograms, showed that the high-molecular weight
dditives PVP and BSA were able to maintain the glass tran-
ition temperature at a higher level after 1 year storage, even
hen larger amounts of plasticizing water were absorbed.
dditionally, crystallization of the formulation was delayed
o higher temperatures when PVP and/or BSA were added to
rehalose. This delay of crystallization was also detected in
he water sorption profiles (Fig. 1): although all components
assed their isothermal glass transition (i.e., RH at which the
lass transition temperature was reduced to 25 ◦C) at 30% RH
detected as an inflection point in the water sorption isotherm
34,40,41]), the moisture-induced crystallization (identified
y a reduction of water content [34,40,41]) occurred at higher
H for the formulations containing PVP and/or BSA. Hence,
hese formulations can be exposed to higher temperature
nd RH, and can absorb more water without their molecules
eaching the mobility necessary for crystallization. Several
uthors have used PVP to stabilize the amorphous state and
xplained this effect by limiting the molecular mobility in
he system due to the addition of high molecular weight
olecules [27–29]. Proteins have been described to limit the
o
s
s
sressed as log10 EID50 per gram powder with the darker bars representing
Some vaccines did not contain a virus concentration above detection limit
d as a minimal loss.
olecular mobility of sugars and prevent crystal nucleation
nd growth due to strong hydrogen bonds between protein
nd sugar [24,42,43].
Pure trehalose crystallized with the formation of trehalose
ihydrate [36,42], as can be derived from the constant water
ontent during the desorption phase (Fig. 1). This hydrate for-
ation was largely prevented by the addition of PVP and/or
SA. However, not all absorbed water could be removed
fter the final drying step of these formulations, which was
reviously related to the formation of small quantities of
ydrate molecules during the sorption phase [34]. Therefore,
he additives apparently could not completely prevent the
ydrate formation of trehalose upon exposure to increasing
umidity.
The evaluation of water sorption is essential in the for-
ulation of dry powder aerosols due to the influence of
ater on the aerosolization properties. Moisture sorption
an induce cohesion by liquid bridging during dispersion,
nd agglomeration via crystallization and formation of solid
ridges during storage [17,35]. The first phenomenon can
xplain the increase in particle size of the trehalose-PVP-
SA powder upon air-assisted dispersion (Table 2) since
apour sorption from the air used to disperse the powder dur-
ng the measuring period most probably caused cohesion of
he powder. This was confirmed by repeating the experiment
ith dried air (using silica gel): the particle size distribution
f the dispersed powder was similar to its primary particle
ize distribution. The other formulations were not as sen-
itive to this short-term moisture effect as their moisture
orption was slower compared to trehalose-PVP-BSA. For
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xample, after exposing the samples for 5 min to 30% RH
comparable to the ambient RH (35%) during the powder dis-
ersion tests), the trehalose-PVP-BSA and trehalose powder
bsorbed 0.4 and 0.1% water, respectively (derived from the
aw DVS data).
However, the median particle size of trehalose-PVP-BSA
id not increase significantly upon storage, while trehalose
howed largely increased particle sizes (Table 3). This was
xplained by the long-term effect of water on the particle
ize, i.e., agglomeration by induction of crystallization or
issolving of the outer layer of the particles and subsequent
ormation of solid bridges (as confirmed for trehalose in
ig. 3). A surface enrichment with PVP and BSA is sug-
ested by the morphology of the particles: the raisin-like
nd collapsed appearance of the formulations containing
VP and BSA, respectively, have both been described previ-
usly and related to highly viscous forces that hinder particle
moothening due to surface enrichment of these components
hen combined with sugars [27,44]. As crystallization has
een described to start at the surface [27], and as PVP and
SA have a higher Tg and lower solubility than trehalose,
he particles were better protected against crystallization or
issolution and subsequent agglomeration compared to pure
rehalose.
Although only minor deagglomeration forces were
pplied, the powders were easily dispersed, as only minor
ifferences were seen between the particle size distribution
n miglyol and the particle size distribution after air-assisted
ispersion (Table 2). This can be explained by the homoge-
eous particle size distribution and the sphericity of particles
Fig. 2). Therefore, a monodisperse particle size distribu-
ion and shielding the powders from environmental humidity
uring storage and dispersion are the main requirements to
nsure easy dispersion of these dry powders.
The powders manufactured with the experimental spray
ryer had a median particle size of about 30m, depend-
ng on the design of the ultrasonic nozzle. These particles
re well suited for primary respiratory vaccination of poul-
ry where deposition in the lower airways should be avoided
o prevent post-vaccination reactions in the more vulnerable
ungs [3–5]. To obtain this, vaccination of 1-day-old chick-
ns should be performed with particles larger than 20m, as
etermined in a previous study [37]. When designing powders
or secondary vaccination (where the lower airways are tar-
eted), the particle size should be reduced below 5 and 10m
or 2- and 4-week-old chickens, respectively [37]. However,
ygroscopic formulations, such as the amorphous powders,
an be subject to hygroscopic growth in the airways [45].
his could decrease the chance that particles reach the lower
irways, even if they are theoretically small enough. Hence, a
on-hygroscopic powder, such as mannitol, could be benefi-
ial for a secondary powder vaccination by avoiding particle
rowth due to moisture sorption.
Spray drying of the Clone 30 vaccine virus with the above-
valuated excipients did not result in loss of vaccine activity,
xcept when the virus was incorporated in crystalline man-
a
t
a
v25 (2007) 8306–8317 8315
itol (Table 4). In contrast, during storage at 6 ◦C, the loss
f infectivity titre was lower in the mannitol matrix than in
he amorphous formulations (Fig. 4). These findings suggest
hat the ND virus did not behave like single proteins when
ncorporated in dry powder formulations. Water replace-
ent with hydrogen bonding between stabilizing sugars
nd proteins is considered to be responsible for stabiliza-
ion during dehydration [46,47]. However, enveloped viruses
uch as the ND virus contain a large amount of lipopro-
eins in their envelope [48], so that water replacement is
n unlikely mechanism of stabilization. Immobilization in
n amorphous matrix [47,49] does stabilize the virus bet-
er during the drying process, but less during storage. This
ay be due to the different structure of single proteins ver-
us viruses. Virus particles, being a complex organization of
roteins, might already have an intrinsic stability as is also
escribed for enzymes consisting of several monomers [50].
s in freeze drying, a possible inactivation mechanism for the
iruses during spray drying and storage might be aggrega-
ion [51]; however, additional research, which was out of the
cope of the current project, should be performed to support
his.
It was possible to prepare powders containing approxi-
ately 108 EID50 of the ND virus per gram powder. Knowing
hat a dose of approximately 103 EID50 of a Clone 30 vac-
ine should be inhaled by a chicken to induce a good immune
esponse [4], it can be calculated that each chicken should
nhale approximately 10g of the here developed powder
accines.
In summary, a stable dry powder formulation of an atten-
ated live Newcastle disease vaccine for respiratory mass
accination of poultry was developed by means of a one-step
pray drying process. The addition of PVP and/or BSA to
rehalose formulations revealed several advantages in solid
tate and particle characteristics. When formulating the vac-
ine in these excipients, the combination of trehalose with
SA (both in the binary trehalose-BSA combination or in
he ternary trehalose-PVP-BSA combination) was beneficial
or the maintenance of vaccine titres during 10 months stor-
ge at 6 and 25 ◦C. Although mannitol crystallized during
pray drying and did not have a good process stability, it was
ble to stabilize the vaccine virus particles during storage at
◦C. Combining the latter with its low hygroscopicity, man-
itol might overcome the disadvantage of loss of titre during
roduction.
In vivo experiments will be performed in the near future
o evaluate the applicability of the dry powder vaccination
oncept. Chickens will be exposed in isolators to the here
eveloped powder formulations and, for comparison, to clas-
ical liquid vaccines. Virus survival in the isolator air will be
easured in order to evaluate whether the virus survives neb-
lization better when incorporated in a powder compared to
liquid. Further, the humoral immune response induced by
he powder and liquid vaccines will be determined to evalu-
te the feasibility of mass vaccination of poultry with powder
accines.
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